In AD models, the strategy for BBB protection mainly aims to upregulate TJ or AJ proteins [245], enhance the expression of Aβ clearance transporters (LRP‐1, ABCB1 [P‐gp]) and ApoE clearance pathway [14], as well as other endothelial pathologies. Here, LRP1 is linked to Alzheimer disease.